Investigating the Safety and Efficacy of Hematopoietic and Mesenchymal Stem Cell Transplantation for Treatment of T1DM: A Systematic Review and Meta-Analysis

Based on the results of this meta-analysis, the MSC and its combination with hematopoietic stem cell could be considered as “Safe Cell” for stem cell transplantation in type 1 diabetes mellitus (T1DM).